Pace Life Sciences Acquires Meridian BioGroup

Velocity Clinical Research Acquires Meridian Clinical Research

December 15, 2022

Healthcare Services

Velocity Clinical Research, a GHO-backed integrated research site organization, has acquired Meridian Clinical Research for an undisclosed amount. The deal creates the largest dedicated clinical research site organization globally (about 80 sites), expands Velocity's U.S. footprint to 25 states and adds Meridian's network of 35+ sites and experienced investigators and staff.

Pace Life Sciences Acquires Biopharma Global

September 8, 2022

Healthcare Services

Pace Life Sciences, a CDMO subsidiary of Pace, has acquired Biopharma Global, a Vienna, Virginia-based regulatory affairs consultancy that specializes in orphan and other high‑unmet‑need drug regulatory support. The acquisition expands Pace's regulatory strategy and submission capabilities for FDA and EMA filings, strengthening its end-to-end development and regulatory services for biotech and pharmaceutical clients.

SD Biosensor and SJL Partners Acquire Meridian Bioscience for $1.53B

July 7, 2022

Medical Devices

A consortium led by SD Biosensor and private equity firm SJL Partners agreed to acquire Meridian Bioscience in an all-cash transaction valued at approximately $1.53 billion ( $34.00 per share). The deal will take Meridian private and is intended to accelerate SD Biosensor's entry into the U.S. in-vitro diagnostics market while leveraging Meridian's U.S. distribution network and product portfolio.

Bioscript Group (backed by Sovereign Capital Partners) Acquires Meridian HealthComms

April 19, 2022

Healthcare Services

Bioscript Group, a Sovereign Capital Partners-backed healthcare communications platform headquartered in Macclesfield, has acquired Meridian HealthComms. The deal is Bioscript's third acquisition since Sovereign backed the management team in March 2021 and expands the group's geographic footprint and service capabilities in medical communications, regulatory writing and market access.

Pace Life Sciences (Pace Analytical) Acquires Drug Delivery Experts

July 23, 2021

Pharmaceuticals

Pace Analytical Life Sciences, a CDMO subsidiary of Pace Analytical Services (itself a portfolio company of Aurora Capital Partners), has acquired Drug Delivery Experts, LLC, a San Diego-based CDMO specializing in complex injectable formulations and drug‑device combination product development. The acquisition expands Pace’s injectable and long‑acting/extended‑release capabilities and brings DDE’s scientific leadership into Pace’s west‑coast operations as DDE transitions to the Pace brand.

Pace Analytical Life Sciences Acquires Bio-Concept Laboratories

December 8, 2020

Pharmaceuticals

Pace Analytical Life Sciences, a subsidiary of Pace Analytical Services, acquired Bio-Concept Laboratories, a Salem, New Hampshire-based pharmaceutical CDMO specializing in sterile aqueous formulation development and fill–finish manufacturing. The deal expands Pace’s sterile materials and ophthalmic manufacturing capabilities to better support clinical trial and drug development programs and strengthens its New England CDMO footprint.